ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 189 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $71,869,000 | +82.7% | 773,286 | +17.1% | 0.02% | +69.2% |
| Q3 2021 | $39,331,000 | -27.3% | 660,447 | -16.8% | 0.01% | -23.5% |
| Q2 2021 | $54,122,000 | +6.5% | 793,526 | +8.3% | 0.02% | 0.0% |
| Q1 2021 | $50,830,000 | +0.6% | 732,583 | +11.4% | 0.02% | -5.6% |
| Q4 2020 | $50,504,000 | -4.9% | 657,324 | -7.4% | 0.02% | -21.7% |
| Q3 2020 | $53,100,000 | +18.6% | 709,957 | -0.2% | 0.02% | +15.0% |
| Q2 2020 | $44,774,000 | +66.4% | 711,284 | +11.0% | 0.02% | +42.9% |
| Q1 2020 | $26,911,000 | -8.9% | 640,765 | -1.5% | 0.01% | +27.3% |
| Q4 2019 | $29,538,000 | -13.4% | 650,325 | -12.7% | 0.01% | -15.4% |
| Q3 2019 | $34,115,000 | -1.4% | 745,358 | +26.4% | 0.01% | 0.0% |
| Q2 2019 | $34,585,000 | +52.4% | 589,906 | +16.6% | 0.01% | +44.4% |
| Q1 2019 | $22,689,000 | +9.8% | 506,129 | -4.6% | 0.01% | 0.0% |
| Q4 2018 | $20,663,000 | +24.9% | 530,482 | +47.5% | 0.01% | +50.0% |
| Q3 2018 | $16,542,000 | – | 359,528 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |